Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats

British Journal of Pharmacology

Volumn 144, Issue 6, 2005, Pages 755-760

  Matos De Moura, Marina ^a   Sousa Dos Santos, Robson Augusto ^a   Peliky Fontes, Marco Antônio ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Ang antagonists; Ang receptors; Cardiovascular system; Tilt test

Indexed keywords

A 779; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7] ANTAGONIST; CANDESARTAN; LOSARTAN; UNCLASSIFIED DRUG; URETHAN;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; TILTING;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; BRADYCARDIA; CARDIOVASCULAR SYSTEM; HYPOTENSION, ORTHOSTATIC; LOSARTAN; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; TIME FACTORS;

EID: 17144404247     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706039     Document Type: Article

References (42)

1. AVERILL, D.B., ISHIYAMA, Y., CHAPPELL, M.C. & FERRARIO, C.M. (2003). Cardiac angiotetisin-(1-7) in ischemic cardiomyopathy. Circulation, 108, 2141-2146.
2. BRAGA, A.N.G., SILVA LEMOS, M., DA SILVA, J.R., FONTES, W.R.P. & SANTOS, R.A.S. (2002). Effects of angiotensins on day-night fluctuations and stress-induced changes in blood pressure. Am. J. Physiol. Reg. Int. Comp. Physiol., 282, R1663-R1671.
3. BROSNIHAN, K.B., LI, P. & FERRARIO, C.M. (1996). Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension, 27, 523-528.
4. CHANSEL, D., BIZET, T., VANDERMEERSCH, S., PHAM, P., LEVY, B. & ARDAILLOU, R. (1994). Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am. J. Physiol., 266, F384-F393.
5. COLLISTER, J.P. & HENDEL, M.D. (2003). The role of Ang-(1-7) in mediating the chronic hypotensive effects of losartan in normal rats. J. Renin Angiotensin Aldosterone Syst., 4, 176-179.
6. DAMPNEY, R.A.L., COLEMAN, M.I., FONTES, M.A.P., HIROOKA, Y., HORIUCHI, J., LI, Y-W., POLSON, J.W., POTTS, P.D. & TAGAWA, T. (2002). Central mechanisms underlying short- and long-term regulation of the cardiovascular system. Clin. Exp. Pharmacol. Physiol., 29, 261-268.
7. FERRARIO, C.M., CHAPPELL, M.C., DEAN, R.H. & IYER, S.N. (1998). Novel angiotensin peptides regulate blood pressure, endothelial function and natriureses. J. Am. Soc. Nephrol., 9, 1716-1722.
8. FERREIRA, A.J., SANTOS, R.A.S. & ALMEIDA, A.P. (2001). Angiotensin-(1-7) cardioprotective effect in myocardial ischemia/reperfusion. Hypertension, 38, 665-668.
9. FONTES, M.A.P., SILVA, L.C.S., CAMPAGNOLE-SANTOS, M.J., KHOSLA, M.C., GUERTZENSTEIN, P.G. & SANTOS, R.A.S. (1994). Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventrolateral medulla acting through specific receptors. Brain Res., 665, 175-180.
10. FONTES, M.A.P., TAGAWA, T., POLSON, J.W., CAVANAGH, S.J. & DAMPNEY, R.A.L. (2001). Descending pathways mediating cardiovascular response from dorsomedial hypothalamic nucleus. Am. J. Physiol. Heart Circ. Physiol., 280, H2891-H2901.
11. GAVRAS, I. & GAVRAS, H. (2000). The antiarrhythmic potential of angiotensin II antagonism: experience with losartan. Am. J. Hypertens., 13, 512-517.
12. GIRONACCI, M.M., ADLER-GRASCHINSKY, E., PEÑA, C. & ENERO, M.A. (1994). Effects of Angiotensin 11 and Angiotensin-(1-7) on the release of [3H] norepinephrine from rat atria. Hypertension, 24, 457-460.
13. GIRONACCI, M.M., COBA, M.P. & PEÑA, C. (1999). Angiotensin-(1-7) binds at the type 1 angiotensin II receptors in rat renal cortex. Regul. Pept., 84, 51-54.
14. GOLIN, R.M.A., GOTOH, E., SAID, S.I. & GANONG, W.F. (1988). Pharmacological evidence that the sympathetic nervous system mediates the increase in renin secretion produced by immobilization and head-up tilt in rats. Neuropharmacology, 27, 1209-1213.
15. GOLIN, R.M.A., KEIL, L.C. & GANONG, W.F. (1991). Effect of head-up tilt on vasopressin secretion and arterial pressure in anesthetized rats. Neuroendocrinology, 54, 42-48.
16. GOTOH, E., MURAKAMI, K., BAHNSON, T.D. & GANONG, W.F. (1987). Role of brain serotonergic pathways and hypothalamus in regulation of renin secretion. Am. J. Physiol., 253, R179-R185.
17. HASHIMOTO, Y., OHASHI, R., MINAMI, K. & NARITA, H. (1999). Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension, Jpn. J. Pharmacol., 81, 63-72.
18. HERINGER-WALTHER, S., BATISTA, E.N., WALTHER, T., KHOSLA, M.C., SANTOS, R.A.S. & CAMPAGNOLE-SANTOS, M.J. (2001). Baroreflex improvement in SHR after ACE inhibition involves angiotensin-(1-7). Hypertension, 37, 1309-1314.
19. JOHNSON, A.K. & GROSS, P.M. (1993). Sensory circumventricular organs and brain homeostatic pathways. FASEB J., 7, 678-686.
20. KERMAN, I.A., MCALLEN, R.M. & YATES, B.J. (2000). Patterning of sympathetic nerve activity in response to vestibular stimulation. Brain Res. Bull. 53, 11-16.
21. LI, Z., BAINS, J.S. & FERGUSON, A.V. (1993). Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat. Brain Res. Bull., 30, 33-39.
22. LOOT, A.E., ROKS, A.J., HENNING, R.H., TIO, R.A., SUURMEIJER, A.J., BOOMSMA, F. & VAN GILST, W.H. (2002). Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation, 105, 1548-1550.
23. METZGER, R., BADER, M., LUDWIG, T., BERBERICH, C, BUNNEMANN, B. & GANTEN, D. (1995). Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett., 357, 27-32.
24. MIKI, K., HAYASHIDA, Y., TAJIMA, F., IWAMOTO, J. & SHIRAKI, K. (1989). Renal sympathetic nerve activity and renal responses during head-up tilt in conscious dogs. Am J. Physiol., 257, R337-R343.
25. OHLSTEIN, E.H., GELLAI, M., BROOKS, D.P., VICKERY, L., JUGUS, J., SULPIZIO, A., RUFFOLO JR, R.R., WEINSTOCK, J. & EDWARDS, R.M. (1992). The antihypertensive effect of the angiotensin II receptor angonist DuP 753 may not be due solely to angiotensin II receptor antagonism. J. Pharmacol. Exp. Ther., 262, 595-601.
26. 1 receptor antagonists to cross the blood-brain barrier in rats. Eur. J. Pharmacol., 307, 259-267.
27. PORSTI, I., BARA, A.T., BUSSE, R. & HECKER, M. (1994). Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br. J. Pharmacol., 111, 652-654.
28. SAMPAIO, W.O., NASCIMENTO, A.S. & SANTOS, R.A.S. (2003). Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am. J. Physiol. Heart Circ. Physiol., 284, H1985-H1994.
29. SANTOS, R.A.S., CAMPAGNOLE-SANTOS, M.J. & ANDRADE, S.P. (2000). Angiotensin-(1-7): an update. Regul. Pept., 91, 45-62.
30. SANTOS, R.A.S., CAMPAGNOLE-SANTOS, M.J., BARACHO, N.C.V., FONTES, M.A.P., SILVA, L.C.S., NEVES, L.A.A., OLIVEIRA, D.R., CALIGIORNE, S.M., RODRIGUES, A.R.V., GROPEN JR, C., CARVALHO, W.S. & SIMÕES E SILVA A.C. KHOSLA, M.C. (1994). Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res. Bull., 35, 293-298.
31. SANTOS, R.A.S., FERREIRA, A.J., NADU, A.P., BRAGA, A.N.G., PINTO DE ALMEIDA, A., CAMPAGNOLE-SANTOS, M.J., BALTATU, O., ILIESCU, R., REUDELHUBER, T.L. & BADER, M. (2004). Expression of angiotensin-(1-7) producing fusion protein produces cardioprotective effects in rats. Physiol. Genomics, 17, 292-299.
32. SANTOS, R.A.S., SIMÕES E SILVA, A.C., MARIC, C., SILVA, D.M.R., MACHADO, R.P., BUHR, I., HERINGER-WALTHER, S., PINHEIRO, S.V.B., LOPES, M.T., BADER, M., MENDES, E.P., LEMOS, V.S., CAMPAGNOLE-SANTOS, M.J., SCHULTHEISS, H.-P., SPETH, R. & WALTHER, T. (2003). Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A., 100, 8258-8263.
33. SHIBOUTA, Y., INADA, Y., OJIMA, M., WADA, T., NODA, M., SANADA, T., KUBO, K., KOHARA, Y., NAKA, T. & NISHIKAWA, K. (1993). Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole- 7-carboxylic acid (CV-11974), and its prodrug, (±)-1- (cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116). J. Pharmacol. Exp. Ther., 266, 114-120.
34. SHIMOKAWA, A., KUNITAKE, T., TAKASAKI, M. & KANNAN, H. (1998). Differential effects of anesthetics on sympathetic nerve activity and arterial baroreceptor reflex in chronically instrumented rats. J. Auton. Nerv. Syst., 72, 46-54.
35. SONG, K., ALLEN, A.M., PAXINOS, G. & MENDELSOHN, F.A.O. (1992). Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J. Comp. Neurol., 316, 467-484.
36. STELLA, A., DAMPNEY, R.A.L., GOLIN, R. & ZANCHETTI, A. (1978). Afferent vagal control of renin release in the anaesthetized cat. Circ. Res., 43, 1107-1111.
37. STELLA, A. & ZANCHETTI, A. (1977). Effects of renal denervation on renin release in response to tilting and furosemida. Am. J. Physiol., 232, H500-H507.
38. 1 receptors in the ventrolateral medulla. Braz. J. Med. Biol. Res., 33, 643-652.
39. THOMAS, G.P., FERRIER, G.R. & HOWLETT, S.E. (1996). Losartan exerts antiarrhythmic activity independent of angiotensin 11 receptor blockade in stimulated ventricular ischemia and reperfusion. J. Pharmacol Exp. Ther., 278, 1090-1097.
40. 1 receptor in the amygdala. J. Neurophysiol., 83, 2012-2021.
41. YATES, B.J., GOTO, T. & BOLTON, P.S. (1993). Responses of neurons in the rostral ventrolateral medulla of the cat to natural vestibular stimulation. Brain Res., 601, 255-264.
42. ZISMAN, L.S., KELLER, R.S., WEAVER, B., LIN, Q., SPETH, R., BRISTOW, M.R. & CANVER, C.C. (2003). Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation, 108, 1707-1712.